These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1303807)

  • 1. Direct immunofluorescence patterns in clinically healthy skin of patients with collagen diseases.
    Velthuis PJ; Kater L; Baart de la Faille H
    Clin Dermatol; 1992; 10(4):423-30. PubMed ID: 1303807
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of cutaneous immunofluorescence in the etiological diagnosis of a disease with antinuclear antibodies].
    Lévêque E; Dréno B; Planchon B; Bureau B; Litoux P; Barrière H
    Ann Dermatol Venereol; 1986; 113(8):655-64. PubMed ID: 3541758
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune deposits in the skin of patients with rheumatoid arthritis.
    McGill PE; Brougham PA; Tulloch J
    J Rheumatol; 1984 Aug; 11(4):454-6. PubMed ID: 6384506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fixation in vivo of antinuclear antibodies].
    Guillet G; Fizet D; Claudy A; Thivolet J
    Nouv Presse Med; 1979 Mar; 8(11):869. PubMed ID: 377217
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of speckled staining of epidermal nuclei in direct immunofluorescence. 10 cases (author's transl)].
    Morel P; Peltier AP; Allegre P; Civatte J
    Nouv Presse Med; 1978 Jul 1-8; 7(27):2377-80. PubMed ID: 353722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on the in vivo reaction of antinuclear antibodies with epidermal cells.
    Izuno GT
    Br J Dermatol; 1978 Apr; 98(4):391-8. PubMed ID: 346041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity and laboratory testing for systemic lupus erythematosus (SLE) and allied diseases.
    Deodhar SD
    Lab Res Methods Biol Med; 1983; 8():89-100. PubMed ID: 6358749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear antibodies and patterns of nuclear immunofluorescence in systemic lupus erythmatosus and other collagen vascular diseases.
    Bhuyan UN; Malaviya AN
    Indian J Med Res; 1976 Jun; 64(6):895-902. PubMed ID: 789235
    [No Abstract]   [Full Text] [Related]  

  • 9. [The direct immunofluorescence skin test in systemic lupus erythematosus. Correlation with the clinical stage of the disease, laboratory changes and nephropathy].
    dos Santos RF; Santiago MB; Yoshinari NH; Rodrigues CJ; Cossermelli W
    Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(4):197-200. PubMed ID: 3074450
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of antinuclear autoantibodies by immunofluorescence technic in collagen diseases].
    Fontaine J; Panisset LC
    Union Med Can; 1969 Aug; 98(8):1274-83. PubMed ID: 4919613
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of autologous or normal skin and fluorescein-labelled anti-C3 serum to increase the sensitivity of immunofluorescence reaction to detect antinuclear antibodies [].
    Vázquez-Escobosa C; Gómez-Estrada H
    Rev Invest Clin; 1982; 34(2):125-8. PubMed ID: 6750732
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous immunofluorescence in ankylosing spondylitis. Absence of correlation with disease activity.
    Peeters AJ; Boom BW; de Rooy-Dijk HH; Westedt ML; Breedveld FC
    J Rheumatol; 1990 Feb; 17(2):234-7. PubMed ID: 2181128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnostic value of titrating antinuclear factors in the serum].
    Permin H; Wiik A; Juhl F; Faber V
    Ugeskr Laeger; 1977 Oct; 139(44):2613-8. PubMed ID: 337610
    [No Abstract]   [Full Text] [Related]  

  • 14. Human necrotizing vasculitis: immunoglobulins and complement in vessel walls of cutaneous lesions and normal skin.
    Sams WM; Claman HN; Kohler PF; McIntosh RM; Small P; Mass MF
    J Invest Dermatol; 1975 Jun; 64(6):441-5. PubMed ID: 237967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinuclear antibodies: study by liver imprint technique.
    Ulrich M; Convit J
    Acta Cient Venez; 1973; 24(1):34-7. PubMed ID: 4590089
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antinuclear antibody: significance of fluorescence patterns].
    Habermann F; de Franco MF
    Rev Hosp Clin Fac Med Sao Paulo; 1981 Jun; 36(3):123-7. PubMed ID: 7034129
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous immunoglobulin therapy is not able to efficiently control cutaneous manifestations in patients with lupus erythematosus.
    De Pità O; Bellucci AM; Ruffelli M; Girardelli CR; Puddu P
    Lupus; 1997; 6(4):415-7. PubMed ID: 9175031
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical usefulness of determining the antibodies to soluble nuclear antigens in various collagen diseases].
    Dziankowska-Bartkowiak B; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Torzecka D; Waszczykowska E
    Przegl Dermatol; 1990; 77(5):332-5. PubMed ID: 2125351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal nuclear immunofluorescence. Is it a specific marker for mixed connective tissue disease?
    Kent LT; Hu CH; Michel B; Tan EM; Moskowitz RW
    J Dermatol; 1984 Apr; 11(2):121-8. PubMed ID: 6384307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.